Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Health»Blue Cross Launches India’s First-Ever Initiative to Stop Period Pain
    Health

    Blue Cross Launches India’s First-Ever Initiative to Stop Period Pain

    WebDeskBy WebDeskNovember 3, 2025No Comments4 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    #StopThePeriodPain – Don’t take period pain lightly. It is a real medical issue.

    New Delhi [India], November 3: In 2020, a single word changed how we looked at health forever: pandemic. COVID-19 became the defining moment of our generation — the first time most of us witnessed a global health crisis unfold in real time. We watched cities lock down, hospitals overflow, and humanity unite to fight an invisible threat. The world’s collective focus was on survival, and we learned how powerful awareness and action could be when everyone comes together for a cause.

    But while we’ve been fighting visible pandemics like COVID-19 — and even tackling chronic diseases such as diabetes, hypertension, and heart ailments through national awareness drives — there’s another silent health crisis that has quietly affected millions of women for decades. One that rarely makes headlines, is barely discussed, and has never been treated like the public health issue it truly is.

    That crisis is Dysmenorrhea, or what most people simply call period pain.

    “Dysmenorrhea, or period pain, affects an estimated 80% of Indian girls and women,”

    explains Dr Prabhu Kasture, Director, Medical Services & Pharmacovigilance at Blue Cross Laboratories.

    “It is, without a doubt, India’s biggest gynaecological problem. Yet, there have been no national campaigns, no government programs, no large-scale education drives to address it. Because somewhere along the way, menstrual pain stopped being viewed as a health issue. It was normalized — brushed aside with a single dismissive line: ‘It’s just part of being a woman.’”

    This cultural conditioning is what the “Stop The Period Pain” campaign aims to change.

    We’ve seen campaigns that have made great strides in menstrual hygiene awareness — promoting the use of sanitary napkins and improving access to basic hygiene products.

    But #StopThePeriodPain is a step beyond hygiene. It’s the first campaign in India that directly addresses the root cause — the pain itself.

    Period

    Ashish Shirsat, Sr. Executive Director, Blue Cross Laboratories, explains it perfectly:

    “‘Period pain to sabko hota hai’ — this one sentence has normalized menstrual pain for generations. It has placed every kind of pain, from mild discomfort to debilitating cramps, into one bucket. But not all pain is normal. Some of it signals deeper health issues — and ignoring it can have lifelong consequences.”

    This normalization has created a dangerous silence around menstrual health.

    Girls miss school. Women skip work. Yet most accept this suffering as something they “just have to deal with.”

    Pachanan Routray, Sr. Marketing Director, Blue Cross Laboratories, adds:

    “We have massive gynaecological problems in India — 80% of girls experience dysmenorrhea. Many of them live with conditions like endometriosis, adenomyosis, or uterine fibroids — all forms of secondary dysmenorrhea — but they go undiagnosed for years because we’ve been taught that period pain is normal. That mindset must change.”

    That’s the heart of the message — excessive period pain is not normal.
    As the campaign says: “Isko halke mein mat lo.”

    The Stop The Period Pain website goes beyond just tools. It’s a complete ecosystem for education and empowerment — featuring personal stories, expert advice, FAQs, and science-backed insights into period pain. It acts as a single, comprehensive guide for girls and women who’ve long suffered in silence, unsure where to turn or what their pain really means.

    The message is simple yet powerful: This is not a small problem. Period pain — or dysmenorrhea — is a silent pandemic that affects millions of Indian women and girls, disrupting their education, careers, and quality of life.

    Just as the world came together to fight COVID-19, it’s time to unite against this invisible yet deeply personal health crisis — through awareness, education, and empathy.

    “Stop The Period Pain” is more than a campaign.
    It’s a movement to change how India talks about women’s health — one conversation, one video, one click at a time.

    About Blue Cross Laboratories

    Founded in 1980 by Chairman Mr. N.H. Israni, Blue Cross Laboratories is one of India’s leading research-based, fast-growing pharmaceutical companies. It provides world-class quality and affordable healthcare products to people across the globe with the aim of improving human life.

    Health
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    WebDesk
    • Website

    Related Posts

    AtHomeCare™ Trials Integrated App to Streamline Post-Discharge Care, Reduce Readmissions

    October 30, 2026

    How India’s Pet Industry Can Be Enhanced with Digital Infrastructure for Information, Intelligence and Trade

    October 29, 2026

    Fredna Vet Diagnostics Uncovers Widespread Bone Tumour in Dog Through Advanced CT Imaging

    October 28, 2026

    Comments are closed.

    Recent Post
    • Lord’s Mark Industries’ Brahamastra Takes Indigenous Defence Innovation to the Global Stage
    • Sudarshan Pharma Q2 Profit Surges 86% to Rs 7.78 Crore as Margins Improve; Revenue Jumps 28%
    • Escorts Kubota to raise tractor prices post-Diwali due to rising input costs
    • Eastern India’s Next Leg Of Growth Will Be Built On District Roads
    • Thyrocare Technologies revenue reaches INR 270.8 Cr in Q2 FY27, grows 25.1% YoY
    • One Analyst, 71,000 Investors: What Made Ankit Jaiswal Build NiveshX
    • SoftTech Engineers introduces CivitTDRx, a Digital-First Approach to Transparent TDR Transactions
    • Lincoln Pharmaceuticals Reports Rs. 57.50 crore Net Profit in H1 FY27, growth of 20.52 percent Y-o-Y

    Type above and press Enter to search. Press Esc to cancel.